The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes

References

• Faber O K, Binder C. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus. Diabetes 1977; 26: 605–10
   PubMed Web of Science ®Google Scholar
• Sjöberg S, Gunnarsson R, Östman J. Residual C-peptide production in type 1 diabetes mellitus. Acta Med Scand 1983; 214: 231–8
   PubMedGoogle Scholar
• Siegler D E, Reeves M L, Skyler J S. Lack of effect of improved glycaemic control on C-peptide secretion in patients without residual beta-cell function. Diabetes Care 1982; 5: 334–6
   PubMedGoogle Scholar
• Gonen B, Goldman J, Baldwin D, Goldberg R B, Ryan W G, Blix P M, Schantzlin D, Frits K H, Rubenstein A H. Metabolic control in diabetic patients. Effect of insulin secretory reserve (measured by plasma C-peptide levels) and circulating insulin antibodies. Diabetes 1979; 28: 749–53
   PubMed Web of Science ®Google Scholar
• Stiller C R, Dupre J, Gent M, Jenner M R, Keown P A, Laupacis A, Martell R, Rodger N W, Graf-Fenried B V, Wolfe B MJ. Effects of cyclosporin immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 1984; 223: 1362–7
   PubMed Web of Science ®Google Scholar
• Faber O K, Regeur L, Lauritzen T, Binder C (1979) The glucagon/C-peptide test in the evaluation of beta-cell function. Proceedings of Symposium on Proinsulin, Insulin and C-peptide. Tokushima, Japan, 1978. Excerpta Med, Amsterdam, 205–10
   Google Scholar
• Madsbad S, Krarup T, McNair P, Christiansen C, Faber O K, Transbøl I, Binder C. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153–6
   PubMedGoogle Scholar
• Groop L C, Pelkonen R, Koskimies S, Botazzo G F, Doniach D. Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care 1986; 9: 129–33
   PubMed Web of Science ®Google Scholar
• Koskinen P, Viikari J, Irjala K, Kaihola H-L, Seppälä P. C-peptide determination in the choice of treatment in diabetes mellitus. Scand J Clin Lab Invest 1985; 45: 131–5
   PubMedGoogle Scholar
• Garvey W T, Olefsky J M, Griffin J, Hamman R F, Kolterman O G. The effect of insulin treatment on insulin secretion and insulin action in type 2 diabetes mellitus. Diabetes 1985; 34: 222–34
   PubMed Web of Science ®Google Scholar
• Damsgaard E M, Frøland A, Green A, Hauge M. An alternative sampling approach to the study of diabetes prevalence. Scand J Soc Med 1984; 12: 115–20
   PubMedGoogle Scholar
• Damsgaard E M. Prevalence and incidence of type 2 diabetes in Denmark compared with other countries. Acta Endocrinologica 1983; 105 (: 131–5, Suppl. 262)
   Google Scholar
• Report of a WHO study group. Diabetes Mellitus. GenevaSwitzerland 1985, Technical Report Series 727
   Google Scholar
• Schmidt F H. Enzymatische Teste zur Schnell-diagnose. Internationales Donau-Symposium uber Diabetes Mellitus, A Beringer. Verlag W. Maudrich, Vienna-Munich-Berna 1973; 3: 567–8
   Google Scholar
• Faber O K, Binder C, Markussen J, Heding L G, Naithani V K, Kuzuya H, Blix P, Horwitz V, Rubenstein A H. Characterization of seven C-peptide antisera. Diabetes 1978; 27(Suppl. 1)170–7
   PubMed Web of Science ®Google Scholar
• Gjessing H J, Damsgaard E M, Matzen L E, Frøland A, Faber O K. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus. Diabetes Care 1987; 10: 558–62
   PubMedGoogle Scholar
• Schellekens A PM, Sanders G TB, Thornton W, Groenestein T. Sources of variation in the column-chromatographic determination of glycohemoglobin. Clin Chem 1981; 27: 94–9
   PubMedGoogle Scholar
• Faber O K, Hagen C, Binder C, Markussen J, Naithani V K, Blix P M, Kuzuya H, Horwitz D L, Rubenstein A H, Rossing N. Kinetics of human connecting peptide in normal and diabetic subjects. J Clin Invest 1978; 62: 197–203
   PubMed Web of Science ®Google Scholar
• Kühl C, Faber O K, Hornnes P, Jensen S L. C-peptide metabolism and the liver. Diabetes 1978; 27(Suppl. 1)197–200
   PubMed Web of Science ®Google Scholar
• Sonksen P H, Tompkins C V, Srivastava M C, Nabarro J DN. A comparative study on the metabolism of human insulin and porcine proinsulin in man. Clin Sci Mol Med 1973; 45: 633–54
   PubMedGoogle Scholar
• Polonsky K S, Rubenstein A H. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 1984; 33: 486–94
   PubMed Web of Science ®Google Scholar
• Damsgaard E M, Faber O K, Frøland A, Iversen S. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function. Acta Endocrinologica 1982; 100: 416–20
   PubMedGoogle Scholar
• Gjessing H J, Matzen L E, Pedersen P C, Faber O K, Frøland A. Insulin requirement in non-insulin dependent diabetes mellitus: Relation to simple tests of islet β-cell function and insulin sensitivity. Diabetic Medicine 1988; 5: 328–32
   PubMedGoogle Scholar
• Ward K W, Bolgiano D C, McKnight B, Halter J B, Porte D. Diminished β-cell secretory capacity in patients with non-insulin dependent diabetes mellitus. J Clin Invest 1984; 74: 1318–28
   PubMed Web of Science ®Google Scholar
• Dimitriadis G D, Pehling G B, Gerich J E. Abnormal glucose modulation of islet α- and β-cell responses to arginine in non-insulin dependent diabetes mellitus. Diabetes 1985; 34: 541–47
   PubMedGoogle Scholar
• Arnold-Larsen S, Madsbad S, Kühl C. Reproducibility of the glucagon test. Diabetic Medicine 1987; 4: 299–303
   PubMed Web of Science ®Google Scholar
• Gjessing H J, Matzen L E, Frøland A, Faber O K. Correlations between fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in insulin treated diabetes. Diabetes Care 1987; 10: 487–90
   PubMedGoogle Scholar
• Yale J-F, Leiter L A, Marliss E B. Urine C-peptide as index of integrated insulin secretion in hypoca-loric states in obese human subjects. Diabetes 1987; 36: 447–53
   PubMedGoogle Scholar
• Takai K, Nonaka K, Ichihara K, Tarui S. Food constituents as a course of variation of C-peptide excretion in the urine. Endocrinol Jpn 1984; 31: 291–9
   PubMedGoogle Scholar
• Blix P M, Boddie-Willis C, Landau R L, Rochman H, Rubenstein A H. Urinary C-peptide: an indicator of β-cell secretion under different metabolic conditions. J Clin Endocrinol Metab 1982; 54: 574–80
   PubMedGoogle Scholar
• Meistas M T, Zadik Z, Margolis S, Kowarski A A. Correlation of urinary excretion of C-peptide with the integrated concentration and secretion rate of insulin. Diabetes 1982; 30: 639–43
   Google Scholar
• Kruszynska Y T, Home P D, Hanning I, Alberti K GMM. Basal and 24-h C-peptide and insulin secretion rate in normal man. Diabetologia 1987; 30: 16–21
   PubMed Web of Science ®Google Scholar